Multiple Sclerosis (MS) Drug Market

RECENT NEWS
New York Times  Oct 31  Comment 
“President Bartlet will call on you at a press conference after he discloses he has multiple sclerosis,” my sister Dottie said over the phone in 2001. Huh?
Motley Fool  Oct 29  Comment 
The MS drug Goliath jumped into development of SP1 modulators last year, but a review of the competitive landscape resulted in a shuttering of the program this quarter, casting doubt on Biogen's future in the blockbuster indication.
NPR  Oct 27  Comment 
Novelist Mat Johnson's mother spent decades trying to escape her MS diagnosis. Johnson looks back on her journey — and what it meant when the disease finally caught up with her.
FierceBiotech  Oct 17  Comment 
Merck KGaA returns PhII multiple sclerosis drug to Apitope ntaylor Mon, 10/17/2016 - 08:48
GenEng News  Oct 17  Comment 
Researchers have discovered that a protein in wheat triggers the inflammation in chronic health conditions, such as multiple sclerosis, asthma, and rheumatoid arthritis, and also contributes toward the development of nonceliac gluten...
newratings.com  Sep 29  Comment 
Actelion to investigate all-oral combination therapy for patients with relapsing multiple sclerosis Actelion Pharmaceuticals Ltd / Actelion to investigate all-oral combination therapy for patients with relapsing multiple sclerosis . Processed...
Motley Fool  Sep 28  Comment 
While Celgene looks to move into the MS space, Biogen isn't going down without a fight




 
TOP CONTRIBUTORS

Very nice site!

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki